标题
Patisiran for the treatment of hereditary transthyretin-mediated amyloidosis
作者
关键词
-
出版物
Expert Review of Clinical Pharmacology
Volume -, Issue -, Pages 1-5
出版商
Informa UK Limited
发表日期
2019-01-16
DOI
10.1080/17512433.2019.1567326
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cerebrospinal fluid and vitreous body exposure to orally administered tafamidis in hereditary ATTRV30M (p.TTRV50M) amyloidosis patients
- (2018) Cecilia Monteiro et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Inhibition of the Amyloidogenesis of Transthyretin by Natural Products and Synthetic Compounds
- (2018) Takeshi Yokoyama et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Family dynamics in transthyretin-related familial amyloid polyneuropathy Val30Met: does genetic risk affect family functioning?
- (2018) Alice Lopes et al. CLINICAL GENETICS
- The genetic heterogeneity of hereditary transthyretin amyloidosis in a sample of the Brazilian population
- (2018) Carolina Lavigne-Moreira et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
- (2018) David Adams et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
- (2018) Merrill D. Benson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oligonucleotide Drugs for Transthyretin Amyloidosis
- (2018) Joel N. Buxbaum NEW ENGLAND JOURNAL OF MEDICINE
- Lipid Nanoparticles Enabling Gene Therapies: From Concepts to Clinical Utility
- (2018) Jayesh A. Kulkarni et al. Nucleic Acid Therapeutics
- Hereditary transthyretin amyloidosis: baseline characteristics of patients in the NEURO-TTR trial
- (2018) Marcia Waddington-Cruz et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Inotersen: First Global Approval
- (2018) Susan J. Keam DRUGS
- Widespread Cardiac and Vasomotor Autonomic Dysfunction in Non-Val30Met Hereditary Transthyretin Amyloidosis
- (2018) Haruki Koike et al. INTERNAL MEDICINE
- The Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical Market
- (2017) Ricardo Titze-de-Almeida et al. PHARMACEUTICAL RESEARCH
- Liver transplantation in transthyretin amyloidosis: Characteristics and management related to kidney disease
- (2017) Ana Rocha et al. Transplantation Reviews
- Efficiency of silencing RNA for removal of transthyretin V30M in a TTR leptomeningeal animal model
- (2016) Paula Gonçalves et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Preclinical evaluation of RNAi as a treatment for transthyretin-mediated amyloidosis
- (2016) James S. Butler et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Current and Future Treatment Approaches in Transthyretin Familial Amyloid Polyneuropathy
- (2016) Philippe Kerschen et al. Current Treatment Options in Neurology
- TTR kinetic stabilizers and TTR gene silencing: a new era in therapy for familial amyloidotic polyneuropathies
- (2016) David Adams et al. EXPERT OPINION ON PHARMACOTHERAPY
- Evolving landscape in the management of transthyretin amyloidosis
- (2015) Philip N. Hawkins et al. ANNALS OF MEDICINE
- Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study
- (2015) Ole B Suhr et al. Orphanet Journal of Rare Diseases
- Drugging RNAi
- (2015) D. Haussecker et al. SCIENCE
- Liver Transplantation for Hereditary Transthyretin Amyloidosis
- (2015) Bo-Göran Ericzon et al. TRANSPLANTATION
- Repurposing Diflunisal for Familial Amyloid Polyneuropathy
- (2015) John L. Berk et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings
- (2014) L. F. Maia et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis
- (2013) Teresa Coelho et al. NEW ENGLAND JOURNAL OF MEDICINE
- Guideline of transthyretin-related hereditary amyloidosis for clinicians
- (2013) Yukio Ando et al. Orphanet Journal of Rare Diseases
- Transthyretin (TTR) Cardiac Amyloidosis
- (2012) Frederick L. Ruberg et al. CIRCULATION
- Cardiac transthyretin amyloidosis
- (2012) Jason N Dungu et al. HEART
- The Transthyretin Amyloidoses: From Delineating the Molecular Mechanism of Aggregation Linked to Pathology to a Regulatory-Agency-Approved Drug
- (2012) Steven M. Johnson et al. JOURNAL OF MOLECULAR BIOLOGY
- Tafamidis for transthyretin familial amyloid polyneuropathy: A randomized, controlled trial
- (2012) T. Coelho et al. NEUROLOGY
- Familial amyloid polyneuropathy
- (2011) Violaine Planté-Bordeneuve et al. LANCET NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More